Inovio Pharmaceuticals Stock Price Patterns
| INO Stock | USD 1.70 0.02 1.16% |
Momentum 42
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.46) | EPS Estimate Current Year (2.34) | EPS Estimate Next Year (1.45) | Wall Street Target Price 7.6333 | EPS Estimate Current Quarter (0.48) |
Using Inovio Pharmaceuticals hype-based prediction, you can estimate the value of Inovio Pharmaceuticals from the perspective of Inovio Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Inovio Pharmaceuticals using Inovio Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Inovio using crowd psychology based on the activity and movement of Inovio Pharmaceuticals' stock price.
Inovio Pharmaceuticals Short Interest
An investor who is long Inovio Pharmaceuticals may also wish to track short interest. As short interest increases, investors should be becoming more worried about Inovio Pharmaceuticals and may potentially protect profits, hedge Inovio Pharmaceuticals with its derivative instruments, or be ready for some potential downside.
200 Day MA 1.9804 | Short Percent 0.1819 | Short Ratio 8.1 | Shares Short Prior Month 11.7 M | 50 Day MA 1.814 |
Inovio Pharmaceuticals Hype to Price Pattern
Investor biases related to Inovio Pharmaceuticals' public news can be used to forecast risks associated with an investment in Inovio. The trend in average sentiment can be used to explain how an investor holding Inovio can time the market purely based on public headlines and social activities around Inovio Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Inovio Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Inovio Pharmaceuticals.
Inovio Pharmaceuticals Implied Volatility | 1.77 |
Inovio Pharmaceuticals' implied volatility exposes the market's sentiment of Inovio Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Inovio Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Inovio Pharmaceuticals stock will not fluctuate a lot when Inovio Pharmaceuticals' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Inovio Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Inovio because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Inovio Pharmaceuticals after-hype prediction price | USD 1.7 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Inovio contract
Based on the Rule 16, the options market is currently suggesting that Inovio Pharmaceuticals will have an average daily up or down price movement of about 0.11% per day over the life of the 2026-05-15 option contract. With Inovio Pharmaceuticals trading at USD 1.7, that is roughly USD 0.001881 . If you think that the market is fully incorporating Inovio Pharmaceuticals' daily price movement you should consider acquiring Inovio Pharmaceuticals options at the current volatility level of 1.77%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Inovio Pharmaceuticals Basic Forecasting Models to cross-verify your projections. Inovio Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Inovio Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Inovio Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Inovio Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Inovio Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Inovio Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Inovio Pharmaceuticals' historical news coverage. Inovio Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.09 and 6.85, respectively. We have considered Inovio Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Inovio Pharmaceuticals is very risky at this time. Analysis and calculation of next after-hype price of Inovio Pharmaceuticals is based on 3 months time horizon.
Inovio Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Inovio Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Inovio Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Inovio Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.05 | 5.15 | 0.00 | 0.01 | 9 Events / Month | 7 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.70 | 1.70 | 0.00 |
|
Inovio Pharmaceuticals Hype Timeline
On the 20th of February Inovio Pharmaceuticals is traded for 1.70. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. Inovio is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is estimated to be very small, whereas the daily expected return is currently at 0.05%. %. The volatility of related hype on Inovio Pharmaceuticals is about 2487.92%, with the expected price after the next announcement by competition of 1.69. About 50.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 2.81. Inovio Pharmaceuticals had not issued any dividends in recent years. The entity had 1:12 split on the 25th of January 2024. Considering the 90-day investment horizon the next estimated press release will be in about 9 days. Check out Inovio Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Inovio Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Inovio Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Inovio Pharmaceuticals' future price movements. Getting to know how Inovio Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Inovio Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ABOS | Acumen Pharmaceuticals | (0.12) | 6 per month | 4.02 | 0.12 | 9.94 | (6.81) | 38.93 | |
| IRD | Opus Genetics | (0.14) | 8 per month | 3.92 | 0.21 | 9.77 | (7.41) | 22.40 | |
| AGEN | Agenus Inc | (1.01) | 8 per month | 0.00 | (0.09) | 6.63 | (6.79) | 30.06 | |
| SEER | Seer Inc | 0.01 | 8 per month | 1.46 | (0.01) | 3.72 | (2.21) | 9.37 | |
| SPRO | Spero Therapeutics | (0.05) | 5 per month | 0.00 | (0.08) | 3.64 | (5.04) | 9.72 | |
| FATE | Fate Therapeutics | 0.02 | 13 per month | 3.83 | 0.12 | 8.00 | (7.56) | 22.03 | |
| MCRB | Seres Therapeutics | (0.24) | 6 per month | 0.00 | (0.08) | 6.64 | (11.49) | 71.55 | |
| VTGN | VistaGen Therapeutics | (0.01) | 9 per month | 0.00 | (0.12) | 9.80 | (12.80) | 96.59 | |
| ALEC | Alector | 0.08 | 5 per month | 2.42 | 0.22 | 5.63 | (4.70) | 18.01 | |
| ACTU | Actuate Therapeutics Common | (0.61) | 6 per month | 0.00 | (0.12) | 6.79 | (8.67) | 20.01 |
Inovio Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Inovio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Inovio using various technical indicators. When you analyze Inovio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Inovio Pharmaceuticals Predictive Indicators
The successful prediction of Inovio Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Inovio Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Inovio Pharmaceuticals based on analysis of Inovio Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Inovio Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Inovio Pharmaceuticals's related companies. | 2025 | 2026 (projected) | Dividend Yield | 0.005012 | 0.005263 | Price To Sales Ratio | 205.43 | 195.16 |
Pair Trading with Inovio Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Inovio Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inovio Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Inovio Stock
| 0.73 | 8VP1 | AVRICORE HEALTH INC | PairCorr |
| 0.72 | VALN | Valneva SE ADR | PairCorr |
| 0.66 | GXEA | Galapagos NV Earnings Call This Week | PairCorr |
| 0.63 | DRTS | Alpha Tau Medical | PairCorr |
| 0.6 | 6C1 | CytomX Therapeutics | PairCorr |
| 0.52 | AVH | Avita Medical | PairCorr |
The ability to find closely correlated positions to Inovio Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Inovio Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Inovio Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Inovio Pharmaceuticals to buy it.
The correlation of Inovio Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inovio Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inovio Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Inovio Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Inovio Pharmaceuticals Basic Forecasting Models to cross-verify your projections. To learn how to invest in Inovio Stock, please use our How to Invest in Inovio Pharmaceuticals guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Will Biotechnology sector continue expanding? Could Inovio diversify its offerings? Factors like these will boost the valuation of Inovio Pharmaceuticals. Market participants price Inovio higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Inovio Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (2.81) | Revenue Per Share | Quarterly Revenue Growth 0.14 | Return On Assets | Return On Equity |
Understanding Inovio Pharmaceuticals requires distinguishing between market price and book value, where the latter reflects Inovio's accounting equity. The concept of intrinsic value - what Inovio Pharmaceuticals' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Inovio Pharmaceuticals' price substantially above or below its fundamental value.
Please note, there is a significant difference between Inovio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Inovio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Inovio Pharmaceuticals' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.